P-01Recovery84 studies indexed

BPC-157

The body's pit crew for repair.

By HelixHouse Research TeamPublished Last reviewed
01 · Overview

BPC-157 (Body Protection Compound-157) is a synthetic 15-amino-acid fragment derived from a protective protein originally isolated from human gastric juice. It's the most-studied peptide in the recovery category — most talked-about for musculoskeletal, tendon, and gut applications. Think of it less as a healing potion and more as handing the body a toolbox that says: fix this faster.

02 · Mechanism of Action

Upregulates growth factors (VEGF, FGF), promotes angiogenesis (new blood vessel formation) at injury sites, modulates the nitric oxide system, and interacts with the dopaminergic and serotonergic systems. In the gut, it appears to protect the mucosal lining and speed ulcer healing. In tendon and ligament tissue, it accelerates fibroblast migration.

03 · Current Evidence
  • E.01Robust preclinical evidence for accelerated tendon-to-bone healing in rat Achilles and quadriceps models.
  • E.02Consistent gastroprotective effects across NSAID-induced and stress-induced ulcer models.
  • E.03Emerging evidence for neuroprotection and traumatic brain injury recovery in rodents.
  • E.04Human clinical trials remain limited — most positive data is preclinical.
04 · Reported Benefits
B.01Faster recovery from tendon, ligament, and muscle injuries
B.02Reduced gut inflammation and improved GI barrier function
B.03Reduced joint pain and post-training soreness
B.04Anecdotal reports of improved sleep and mood
05 · Safety Considerations

Very favorable preclinical safety profile — no significant toxicity found across a wide dose range in animal studies. Not approved by the FDA for clinical use in the US; regulatory status as a research compound. Not for use during pregnancy or in individuals with active cancer.

06 · Common Stacks

Commonly stacked with TB-500 for compounded soft-tissue repair, and with GHK-Cu for skin and connective tissue.

07 · Regulatory Status

Research use only. Not FDA-approved for human therapy.

08 · References & Further Reading
09 · Frequently Asked Questions
How does BPC-157 work?+
Upregulates growth factors (VEGF, FGF), promotes angiogenesis (new blood vessel formation) at injury sites, modulates the nitric oxide system, and interacts with the dopaminergic and serotonergic systems. In the gut, it appears to protect the mucosal lining and speed ulcer healing. In tendon and ligament tissue, it accelerates fibroblast migration.
What are the reported benefits of BPC-157?+
Faster recovery from tendon, ligament, and muscle injuries Reduced gut inflammation and improved GI barrier function Reduced joint pain and post-training soreness Anecdotal reports of improved sleep and mood Note: reported benefits vary and much of the evidence is preclinical.
Is BPC-157 safe?+
Very favorable preclinical safety profile — no significant toxicity found across a wide dose range in animal studies. Not approved by the FDA for clinical use in the US; regulatory status as a research compound. Not for use during pregnancy or in individuals with active cancer.
What is the regulatory status of BPC-157?+
Research use only. Not FDA-approved for human therapy.
Educational content only · Reviewed July 8, 2026 by HelixHouse Research Team

This page summarizes publicly available research. Nothing here is medical advice, a prescription, or a diagnosis. Peptides described are not FDA-approved for the uses discussed unless explicitly noted. Consult a qualified physician before starting any protocol.